Ngā hua rapu kaituhi

1

Vascular pathology and osteoarthritis mā David M. Findlay

I whakaputaina 2007

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
2

Bone–cartilage crosstalk: a conversation for understanding osteoarthritis mā David M. Findlay, J.S. Kuliwaba

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
3

Osteoblast-Chondrocyte Interactions in Osteoarthritis mā David M. Findlay, Gerald J. Atkins

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
4

Microarray gene expression profiling of osteoarthritic bone suggests altered bone remodelling, WNT and transforming growth factor-β/bone morphogenic protein signalling mā Blair Hopwood, Anna Tsykin, David M. Findlay, Nicola L. Fazzalari

I whakaputaina 2007

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

Calcitonin induction of a persistent activated state of adenylate cyclase in human breast cancer cells (T 47D). mā S.J. Lamp, David M. Findlay, Jane M. Moseley, T. John Martin

I whakaputaina 1981

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

Time for a change: addressing R&D and commercialization challenges for antibacterials mā David Payne, Linda Miller, David M. Findlay, James W. Anderson, Lynn Marks

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
7

Zoledronic Acid Inhibits Both the Osteolytic and Osteoblastic Components of Osteosarcoma Lesions in a Mouse Model mā Agatha Labrinidis, Shelley Hay, Vasilios Liapis, Vladimir Ponomarev, David M. Findlay, Andreas Evdokiou

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

Bone marrow lesions in osteoarthritis: What lies beneath mā Tamara Alliston, Christopher J. Hernandez, David M. Findlay, David T. Felson, Oran D. Kennedy

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
9

The Ratio of Messenger RNA Levels of Receptor Activator of Nuclear Factor κB Ligand to Osteoprotegerin Correlates with Bone Remodeling Indices in Normal Human Cancellous Bone but N... mā Nicola L. Fazzalari, J.S. Kuliwaba, Gerald J. Atkins, Mark R. Forwood, David M. Findlay

I whakaputaina 2001

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Calcitonin receptors, bone sialoprotein and osteopontin are expressed in primary breast cancers mā Matthew T. Gillespie, Rachel J. Thomas, Zhao-Yan Pu, Hong Zhou, T. John Martin, David M. Findlay

I whakaputaina 1997

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint mā David R. Haynes, Tania N. Crotti, M Loric, Gretchen Bain, Gerald J. Atkins, David M. Findlay

I whakaputaina 2001

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to apo2l/trail‐induced apoptosis mā Andreas Evdokiou, Stelios Bouralexis, Gerald J. Atkins, Fugui Chai, Shelley Hay, Mark Clayer, David M. Findlay

I whakaputaina 2002

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway mā Asiri R. Wijenayaka, Masakazu Kogawa, Hui Peng Lim, Lynda F. Bonewald, David M. Findlay, Gerald J. Atkins

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
14

Osteoclastic Metabolism of 25(OH)-Vitamin D3: A Potential Mechanism for Optimization of Bone Resorption mā Masakazu Kogawa, David M. Findlay, Paul Anderson, Renee T. Ormsby, C. Vincent, Howard A. Morris, Gerald J. Atkins

I whakaputaina 2010

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

Bone marrow lesions in knee osteoarthritis: regional differences in tibial subchondral bone microstructure and their association with cartilage degeneration mā Dzenita Muratovic, David M. Findlay, Flavia Cicuttini, Anita E. Wluka, Y.R. Lee, Suzanne Edwards, J.S. Kuliwaba

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

Critical role of p38 MAPK for regeneration of the sciatic nerve following crush injury in vivo mā Naoki Kato, Masahito Matsumoto, Masakazu Kogawa, Gerald J. Atkins, David M. Findlay, Takahiko Fujikawa, Hiromi Oda, Masato Ogata

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

The Nitrogen-Containing Bisphosphonate, Zoledronic Acid, Influences RANKL Expression in Human Osteoblast-Like Cells by Activating TNF-α Converting Enzyme (TACE) mā Bei-Qing Pan, Amanda Farrugia, Luen Bik To, David M. Findlay, Jonathan Green, Kevin Lynch, Andrew C.W. Zannettino

I whakaputaina 2004

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis mā David R. Haynes, Tania N. Crotti, Austin Potter, M Loric, Gerald J. Atkins, Donald W. Howie, David M. Findlay

I whakaputaina 2001

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
19

Novel Insights into Staphylococcus aureus Deep Bone Infections: the Involvement of Osteocytes mā Dongqing Yang, Asiri R. Wijenayaka, Lucian B. Solomon, Stephen Pederson, David M. Findlay, Stephen P. Kidd, Gerald J. Atkins

I whakaputaina 2018

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
20

Sclerostin Regulates Release of Bone Mineral by Osteocytes by Induction of Carbonic Anhydrase 2 mā Masakazu Kogawa, Asiri R. Wijenayaka, Renee T. Ormsby, Gethin Thomas, Paul Anderson, Lynda F. Bonewald, David M. Findlay, Gerald J. Atkins

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - David M. Findlay

Vascular pathology and osteoarthritis mā David M. Findlay

Bone–cartilage crosstalk: a conversation for understanding osteoarthritis mā David M. Findlay, J.S. Kuliwaba

Osteoblast-Chondrocyte Interactions in Osteoarthritis mā David M. Findlay, Gerald J. Atkins

Microarray gene expression profiling of osteoarthritic bone suggests altered bone remodelling, WNT and transforming growth factor-β/bone morphogenic protein signalling mā Blair Hopwood, Anna Tsykin, David M. Findlay, Nicola L. Fazzalari

Calcitonin induction of a persistent activated state of adenylate cyclase in human breast cancer cells (T 47D). mā S.J. Lamp, David M. Findlay, Jane M. Moseley, T. John Martin

Time for a change: addressing R&amp;D and commercialization challenges for antibacterials mā David Payne, Linda Miller, David M. Findlay, James W. Anderson, Lynn Marks

Zoledronic Acid Inhibits Both the Osteolytic and Osteoblastic Components of Osteosarcoma Lesions in a Mouse Model mā Agatha Labrinidis, Shelley Hay, Vasilios Liapis, Vladimir Ponomarev, David M. Findlay, Andreas Evdokiou

Bone marrow lesions in osteoarthritis: What lies beneath mā Tamara Alliston, Christopher J. Hernandez, David M. Findlay, David T. Felson, Oran D. Kennedy

The Ratio of Messenger RNA Levels of Receptor Activator of Nuclear Factor κB Ligand to Osteoprotegerin Correlates with Bone Remodeling Indices in Normal Human Cancellous Bone but N... mā Nicola L. Fazzalari, J.S. Kuliwaba, Gerald J. Atkins, Mark R. Forwood, David M. Findlay

Calcitonin receptors, bone sialoprotein and osteopontin are expressed in primary breast cancers mā Matthew T. Gillespie, Rachel J. Thomas, Zhao-Yan Pu, Hong Zhou, T. John Martin, David M. Findlay

Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint mā David R. Haynes, Tania N. Crotti, M Loric, Gretchen Bain, Gerald J. Atkins, David M. Findlay

Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to apo2l/trail‐induced apoptosis mā Andreas Evdokiou, Stelios Bouralexis, Gerald J. Atkins, Fugui Chai, Shelley Hay, Mark Clayer, David M. Findlay

Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway mā Asiri R. Wijenayaka, Masakazu Kogawa, Hui Peng Lim, Lynda F. Bonewald, David M. Findlay, Gerald J. Atkins

Osteoclastic Metabolism of 25(OH)-Vitamin D3: A Potential Mechanism for Optimization of Bone Resorption mā Masakazu Kogawa, David M. Findlay, Paul Anderson, Renee T. Ormsby, C. Vincent, Howard A. Morris, Gerald J. Atkins

Bone marrow lesions in knee osteoarthritis: regional differences in tibial subchondral bone microstructure and their association with cartilage degeneration mā Dzenita Muratovic, David M. Findlay, Flavia Cicuttini, Anita E. Wluka, Y.R. Lee, Suzanne Edwards, J.S. Kuliwaba

Critical role of p38 MAPK for regeneration of the sciatic nerve following crush injury in vivo mā Naoki Kato, Masahito Matsumoto, Masakazu Kogawa, Gerald J. Atkins, David M. Findlay, Takahiko Fujikawa, Hiromi Oda, Masato Ogata

The Nitrogen-Containing Bisphosphonate, Zoledronic Acid, Influences RANKL Expression in Human Osteoblast-Like Cells by Activating TNF-α Converting Enzyme (TACE) mā Bei-Qing Pan, Amanda Farrugia, Luen Bik To, David M. Findlay, Jonathan Green, Kevin Lynch, Andrew C.W. Zannettino

The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis mā David R. Haynes, Tania N. Crotti, Austin Potter, M Loric, Gerald J. Atkins, Donald W. Howie, David M. Findlay

Novel Insights into Staphylococcus aureus Deep Bone Infections: the Involvement of Osteocytes mā Dongqing Yang, Asiri R. Wijenayaka, Lucian B. Solomon, Stephen Pederson, David M. Findlay, Stephen P. Kidd, Gerald J. Atkins

Sclerostin Regulates Release of Bone Mineral by Osteocytes by Induction of Carbonic Anhydrase 2 mā Masakazu Kogawa, Asiri R. Wijenayaka, Renee T. Ormsby, Gethin Thomas, Paul Anderson, Lynda F. Bonewald, David M. Findlay, Gerald J. Atkins

Ngā utauta rapu:

Ngā marau whai pānga

Time for a change: addressing R&D and commercialization challenges for antibacterials mā David Payne, Linda Miller, David M. Findlay, James W. Anderson, Lynn Marks